Industry News

Industry News

Progression Of Glioblastoma May Be Accelerated By Cytomegalovirus

Jun 04, 2013

A virus that infects most Americans but that usually remains dormant in the body might speed the progression of an aggressive form of brain cancer when particular genes are shut off in tumor cells, new research shows. The animal study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read More

MarginProbe System Makes Breast Cancer Surgery More Precise

Jun 04, 2013

Any breast cancer surgeon who regularly performs lumpectomies confronts the question "Did I get it all?" Thirty to 60 percent of the time in the U.S., the answer is "no," requiring the patient to undergo a second surgery to remove the remaining tumor... Read More

In Metastatic Uveal Melanoma, New Drug Improves Progression-Free Survival, Shrinks Tumors

Jun 04, 2013

The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma, according to new Memorial Sloan-Kettering Cancer Center research presented at the 49th annual meeting of the American Society of Clinical Oncology (ASCO). The findings are potentially practice-changing for a historically "untreatable disease... Read More

Crizotinib's Superiority To Chemotherapy For ALK-positive Lung Cancer Confirmed; First Crizotinib Resistance In ROS1-positive Lung Tumor

Jun 04, 2013

Research teams led by Massachusetts General Hospital (MGH) Cancer Center investigators are publishing two important studies regarding use of the targeted cancer drug crizotinib for treatment of advanced lung cancer driven by specific genetic mutations... Read More

Lung Cancer Outcomes Boosted By Targeted Therapy

Jun 04, 2013

Thousands of patients with an advanced form of lung cancer that carries a specific dysfunctional gene are likely to fare better if treated with a targeted therapy than with traditional chemotherapy, report Dana-Farber Cancer Institute researchers and a team of international collaborators... Read More

Long-Term Sex Partners Of People With HPV-Related Oral Cancers Not At Increased Risk Of Infection

Jun 04, 2013

Spouses and long-term partners of patients with mouth and throat cancers related to infection with the human papilloma virus (HPV) appear to have no increased prevalence of oral HPV infections, according to results of a multicenter, pilot study led by Johns Hopkins investigators. The study's results suggest that long-term couples need not change their sexual practices, say the scientists... Read More

Personalized Strategies For Pretesting Cervical Tumors

Jun 04, 2013

Doctors at Washington University School of Medicine in St. Louis have shown that testing cervical tumors before treatment for vulnerability to chemotherapy predicts whether patients will do well or poorly with standard treatment. The study supports the future possibility of personalized medicine for cervical cancer, a tumor normally addressed with a one-size-fits-all approach... Read More

Cheap Vinegar Test Detects Cervical Cancer

Jun 04, 2013

A remarkably simple vinegar test in India has managed to lower the rate of cervical cancer deaths by one-third. Healthcare professionals have said that the outcome of the test has been "incredible", stating that it is capable of saving millions of lives... Read More

Cancer Patients In The US Are Suffering From Drug Shortages

Jun 04, 2013

Eighty-three percent of cancer doctors have documented that they have experienced oncology drug shortages. Most of them also say their patients' treatments have been affected, according to a study presented at the 2013 American Society of Clinical Oncology... Read More

Glioblastoma Patients Treated With Bevacizumab Experience Reduced Cognitive Function And Quality Of Life

Jun 04, 2013

Many glioblastoma patients treated with bevacizumab (AvastinĀ®) have significant deterioration in neurocognitive function, symptoms and quality of life. Not only that, the changes often predict treatment outcomes, according to new research from The University of Texas MD Anderson Cancer Center... Read More

Previous Page   Next Page